Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02903472 · ClinicalTrials.gov registry record
Gastrointestinal and Urinary Tract Microbiome After SCI
A clinical trial, sponsored by University of British Columbia.
- Completed
- Registry status
- 43
- Enrollment target
NCT02903472 is a clinical trial that has completed, run by University of British Columbia. The registered enrollment target is 43 participants.
The verdict
NCT02903472 has completed, sponsored by University of British Columbia.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
Changes in the GI microbiota and/or metabolomics have been linked to evolving transformations in immune system function and infection rates in experimental SCI in animal models. A recent study involving chronic survivors of SCI show distinct GI microbiome changes in comparison to healthy controls. GI microbial metabolism of dietary components has been causally linked to various health conditions, such as cardiovascular disease, infections, which is an ongoing concern for chronic SCI survivors. It is probable that alterations of GI microbiota are established acutely after SCI and could subsequently alter medical care and impact health outcomes for people living with SCI. This project is a pilot study to describe any changes in the GI and urinary tract microbiota as they appear over the first year after SCI. When available, data on factors, other than SCI, that may impact change in the gut microbiome after SCI will also be noted, including: * the level and severity of SCI, * the time since SCI, * the person's immune profile, * the antibiotic regimen of the individual and time since antibiotic administration, * the incidence and type of infections after SCI and * the person's diet or activities after SCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02903472
The ClinicalTrials.gov registry entry for NCT02903472 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of British Columbia, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02903472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02903472 about?
NCT02903472 is a clinical study titled "Gastrointestinal and Urinary Tract Microbiome After SCI". Changes in the GI microbiota and/or metabolomics have been linked to evolving transformations in immune system function and infection rates in experimental SCI in animal models. A recent study involving chronic survivors of SCI show distinct GI microbiome changes in comparison to healthy controls. G...
What is the current status of trial NCT02903472?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2017-09-01. Estimated completion is 2020-12-31.
Who is sponsoring clinical trial NCT02903472?
This trial is sponsored by University of British Columbia, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.